• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MELD、Child-Pugh和埃默里模型在经颈静脉肝内门体分流术患者生存预测中的比较

Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.

作者信息

Schepke Michael, Roth Felix, Fimmers Rolf, Brensing Karl August, Sudhop Thomas, Schild Hans H, Sauerbruch Tilman

机构信息

Department of Internal Medicine I, University of Bonn, Bonn, Germany.

出版信息

Am J Gastroenterol. 2003 May;98(5):1167-74. doi: 10.1111/j.1572-0241.2003.07515.x.

DOI:10.1111/j.1572-0241.2003.07515.x
PMID:12809844
Abstract

OBJECTIVES

Recently, new prognostic models (Model for End-Stage Liver Disease [MELD model] and Emory score) were proposed for the prediction of survival in transjugular intrahepatic portosystemic shunt (TIPS) patients. Although the MELD model is considered to be superior and has consecutively been applied to priority listing for liver transplantation, these models have never been directly compared in terms of long-term prognosis. We therefore compared the prognostic accuracy of the different models, including the Child-Pugh score, in an unselected cohort of TIPS patients followed long-term.

METHODS

Baseline risk scores for 162 unselected consecutive TIPS patients followed until death (n = 81), liver transplantation, or end of observation (n = 81) (mean follow-up 30.7 +/- 26.4 months) were calculated, and respective concordance- (c-)statistics for the predictive accuracy of 3-, 12-, and 36-month survival for the three models were compared statistically.

RESULTS

All three models predicted short-term (3-month) survival with similar accuracy. The MELD model generated the best c-statistics for both 12-month (c-statistic 0.73, 95% CI = 0.64-0.82) and 36-month survival (c-statistic 0.74, 95% CI = 0.64-0.84). The predictive accuracy of the Emory score was significantly lower (c-statistic for 12-month survival: 0.60, 95% CI = 0.52-0.68, p = 0.012 vs MELD). In the statistical comparison of the MELD and the Child-Pugh model, only a trend favoring MELD for the prediction of 1-yr survival in patients with intestinal bleeding could be observed (MELD: c-statistic 0.78, 95% CI = 0.67-0.89; Child-Pugh: c-statistic 0.67, 95% CI = 0.55-0.80, p = 0.059).

CONCLUSIONS

The MELD model is superior to the Emory score but only slightly superior to the Child-Pugh classification for the prediction of long-term survival in TIPS patients.

摘要

目的

最近,有人提出了新的预后模型(终末期肝病模型[MELD模型]和埃默里评分)来预测经颈静脉肝内门体分流术(TIPS)患者的生存率。尽管MELD模型被认为更具优势,且已连续应用于肝移植优先排队名单,但这些模型在长期预后方面从未进行过直接比较。因此,我们在一个未经过筛选的长期随访的TIPS患者队列中,比较了包括Child-Pugh评分在内的不同模型的预后准确性。

方法

计算了162例未经过筛选的连续TIPS患者的基线风险评分,这些患者随访至死亡(n = 81)、肝移植或观察结束(n = 81)(平均随访30.7±26.4个月),并对这三种模型预测3个月、12个月和36个月生存率的预测准确性的各自一致性(c-)统计量进行了统计学比较。

结果

所有三种模型预测短期(3个月)生存率的准确性相似。MELD模型在预测12个月生存率(c统计量0.73,95%CI = 0.64 - 0.82)和36个月生存率(c统计量0.74,95%CI = 0.64 - 0.84)方面产生了最佳的c统计量。埃默里评分的预测准确性显著较低(12个月生存率的c统计量:0.60,95%CI = 0.52 - 0.68,与MELD相比p = 0.012)。在MELD模型和Child-Pugh模型的统计学比较中,仅观察到在预测肠道出血患者1年生存率方面有倾向于MELD的趋势(MELD:c统计量0.78,95%CI = 0.67 - 0.89;Child-Pugh:c统计量0.67,95%CI = 0.55 - 0.80,p = 0.059)。

结论

对于预测TIPS患者的长期生存率,MELD模型优于埃默里评分,但仅略优于Child-Pugh分级。

相似文献

1
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.MELD、Child-Pugh和埃默里模型在经颈静脉肝内门体分流术患者生存预测中的比较
Am J Gastroenterol. 2003 May;98(5):1167-74. doi: 10.1111/j.1572-0241.2003.07515.x.
2
[MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].[终末期肝病模型(MELD)评分对经颈静脉肝内门体分流术(TIPS)治疗的顽固性腹水患者早期死亡率的预测作用]
Vnitr Lek. 2006 Sep;52(9):771-6.
3
[New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].[肝硬化和肝细胞癌严重程度结局的新评分系统:关于Child-Turcotte-Pugh评分和终末期肝病模型(MELD)评分的当前问题]
Taehan Kan Hakhoe Chi. 2003 Sep;9(3):167-79.
4
Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.肝硬化的病因对终末期肝病模型评分预测的生存率有影响。
Eur J Clin Invest. 2009 Jan;39(1):65-71. doi: 10.1111/j.1365-2362.2008.02063.x.
5
MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.终末期肝病模型(MELD)评分作为接受择期经颈静脉肝内门体分流术(TIPS)患者早期死亡的预测指标。
Cardiovasc Intervent Radiol. 2005 May-Jun;28(3):307-12. doi: 10.1007/s00270-004-0145-y.
6
Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?纳入血清肌酐值能否改善Child-Turcotte-Pugh评分,并在肝硬化患者的短期预后评估中对终末期肝病模型评分的预后价值提出挑战?
Liver Int. 2004 Oct;24(5):465-70. doi: 10.1111/j.1478-3231.2004.0949.x.
7
MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.在预测经颈静脉肝内门体分流术患者的3个月生存率方面,终末期肝病模型(MELD)评分优于Child-Pugh评分。
J Hepatol. 2002 Apr;36(4):494-500. doi: 10.1016/s0168-8278(01)00309-9.
8
Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.终末期肝病模型(DeltaMELD)评分随时间增加作为晚期肝硬化患者预后预测指标的评估:危险因素分析及与初始MELD和Child-Turcotte-Pugh评分的比较
J Hepatol. 2005 Jun;42(6):826-32. doi: 10.1016/j.jhep.2005.01.019. Epub 2005 Mar 31.
9
The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.丙氨酸氨基转移酶与天冬氨酸氨基转移酶比值及终末期肝病模型评分对病毒性肝硬化患者的1年和3个月预后评估价值
Am J Gastroenterol. 2002 Nov;97(11):2855-60. doi: 10.1111/j.1572-0241.2002.07053.x.
10
Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management.布加综合征的预后指标:对临床研究有效,但对个体治疗不足。
Am J Gastroenterol. 2009 May;104(5):1140-6. doi: 10.1038/ajg.2009.63. Epub 2009 Mar 31.

引用本文的文献

1
Hepatic cirrhosis and decompensation: Key indicators for predicting mortality risk.肝硬化及其失代偿:预测死亡风险的关键指标。
World J Hepatol. 2025 Mar 27;17(3):104580. doi: 10.4254/wjh.v17.i3.104580.
2
Frailty as a risk-stratification tool in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).衰弱作为经颈静脉肝内门体分流术(TIPS)患者的一种风险分层工具。
J Frailty Sarcopenia Falls. 2023 Jun 1;8(2):83-93. doi: 10.22540/JFSF-08-083. eCollection 2023 Jun.
3
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan.
首报 4 例肝硬化腹水对托伐普坦抵抗患者经颈静脉肝内门体分流术的临床疗效。
BMJ Open Gastroenterol. 2023 Apr;10(1). doi: 10.1136/bmjgast-2023-001120.
4
Novel CABIN score outperforms other prognostic models in predicting in-hospital mortality after salvage transjugular intrahepatic portosystemic shunting.新型CABIN评分在预测挽救性经颈静脉肝内门体分流术后院内死亡率方面优于其他预后模型。
World J Gastrointest Pathophysiol. 2023 Mar 22;14(2):34-45. doi: 10.4291/wjgp.v14.i2.34.
5
Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed.8 小时内行紧急抢救性经颈静脉肝内门体分流术可提高难治性静脉曲张出血患者的生存率。
Hepatol Int. 2023 Aug;17(4):954-966. doi: 10.1007/s12072-022-10479-5. Epub 2023 Feb 14.
6
The Potential Role of Model for End-Stage Liver Disease (MELD)-Sodium Score in Predicting the Severity of Acute Pancreatitis.终末期肝病模型(MELD)-钠评分在预测急性胰腺炎严重程度中的潜在作用
Cureus. 2022 Dec 31;14(12):e33198. doi: 10.7759/cureus.33198. eCollection 2022 Dec.
7
FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts.FIB-4和APRI作为经颈静脉肝内门体分流术患者短期和长期生存的预测因素
Biomedicines. 2022 Apr 28;10(5):1018. doi: 10.3390/biomedicines10051018.
8
A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS - Modified TIPS Score.一种新型评分可预测经颈静脉肝内门体分流术后的死亡率:MOTS-改良 TIPS 评分。
Liver Int. 2022 Aug;42(8):1849-1860. doi: 10.1111/liv.15236. Epub 2022 Apr 1.
9
External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.FIPS 评分对全国退伍军人事务队列中 TIPS 术后死亡率的外部验证。
Dig Dis Sci. 2022 Sep;67(9):4581-4589. doi: 10.1007/s10620-021-07307-5. Epub 2021 Nov 19.
10
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.北美门静脉高压经颈静脉肝内门体分流术实践推荐
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.